Dr. Alewine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
37 Rockville Pike
Bldg 37
Bethesda, MD 20892Phone+1 301-496-4000
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
University of Maryland School of MedicineClass of 2008
Clinical Trials
Publications & Presentations
PubMed
- Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization.Theressa Ewa, Neel Panchwagh, Chin-Hsien Tai, Leela Rani Avula, Sarah Joseph
FASEB Journal. 2024-12-13 - Editorial: special issue on the latest advances and challenges in pancreas cancer research in memory of S. Perwez Hussain.Christine Alewine, Curtis C Harris, Anirban Maitra, Sharon R Pine, David Tuveson
Carcinogenesis. 2024-11-22 - Macrophages Under the Influence of Tumor Mesothelin Weaken Host Defenses against Pancreatic Cancer Metastasis.Christine Alewine
Cancer Research. 2024-02-15
Press Mentions
Can Chemo Help KRAS Inhibitors Work Better Against Pancreatic Cancer?August 20th, 2024- New Drug Shows Promise Against Pancreatic Cancer and Breast CancerFebruary 12th, 2021
- Drug Is Promising Against Pancreatic and Breast CancersFebruary 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
